Dexcom (NSDQ:DXCM) topped estimates on Wall Street today with preliminary results for its fourth-quarter financial results.
The San Diego, Calif.-based company said it expects to report $331 million in sales for the quarter ended Dec. 31 – up at least 50% from the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Dexcom Q4 prelims top consensus | Wall Street Beat appeared first on MassDevice.
from MassDevice http://bit.ly/2sghU6k
Cap comentari:
Publica un comentari a l'entrada